Chronic pain as a manifestation of potassium channel-complex autoimmunity
- 11 September 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 79 (11), 1136-1144
- https://doi.org/10.1212/wnl.0b013e3182698cab
Abstract
Objective: Autoantibodies targeting voltage-gated potassium channel (VGKC) complexes cause a spectrum of neuronal hyperexcitability disorders. We investigated pain as a manifestation of VGKC-complex autoimmunity. Methods: We reviewed the prevalence and characteristics of pain in VGKC-complex-immunoglobulin G (IgG)–seropositive patients in 25 months of comprehensive service testing for neural autoantibodies, subtyped positive sera for LGI1-IgG and CASPR2-IgG specificities, and reviewed pain prevalence in autoimmune control patients. Results: VGKC-complex-IgG was identified in 1,992 patients of 54,853 tested (4%). Of 316 evaluated neurologically at Mayo Clinic, 159 (50%) had pain, in isolation (28%) or with accompanying neurologic manifestations (72%), and not attributable to alternative cause. Pain was subacute in onset, chronic in course, neuropathic, nociceptive, regional, or diffuse and sometimes attributed to fibromyalgia (6%) or psychogenic cause (13%). Most patients had normal peripheral nervous system function, measured by neuropathy impairment scores and nerve conduction. Evidence of neuronal hyperexcitability (hyperhidrosis, quantitative heat-pain hyperalgesia, or electromyographic excitability) was 25-fold more common in pain patients. Pain management required multiple medications in 70% (narcotics, 30%); 13 of 16 patients reported pain relief with immunotherapy. Pain was significantly associated with CASPR2-IgG-positivity (16% positive with pain, 7% without pain; p = 0.014) but not with LGI1-IgG. Less than 10% of 167 patients with neural autoantibodies other than VGKC-complex-IgG reported pain. Conclusions: Chronic idiopathic pain is a syndromic manifestation of VGKC-complex autoimmunity. Hyperexcitability of nociceptive pathways is implicated. CASPR2-IgG significantly associates with pain, but in most patients the antigenic VGKC-complex molecule remains to be determined. VGKC-complex autoimmunity represents an important new direction for pain research and therapy.Keywords
This publication has 35 references indexed in Scilit:
- HCN2 Ion Channels Play a Central Role in Inflammatory and Neuropathic PainScience, 2011
- Gain of function NaV1.7 mutations in idiopathic small fiber neuropathyAnnals of Neurology, 2011
- Potassium Channels as a Potential Therapeutic Target for Trigeminal Neuropathic and Inflammatory PainMolecular Pain, 2011
- Neurophysiologic Studies in Morvan SyndromeJournal of Clinical Neurophysiology, 2004
- Potassium channels and pain: present realities and future opportunitiesEuropean Journal of Pharmacology, 2004
- Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibodyNeurology, 2004
- Isaacs' syndrome as a potassium channelopathy of the nerveMuscle & Nerve, 2002
- Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channelsBrain, 2001
- Autoantibodies detected to expressed K+ channels are implicated in neuromyotoniaAnnals of Neurology, 1997
- Acquired neuromyotonia: Evidence for autoantibodies directed against K+channels of peripheral nervesAnnals of Neurology, 1995